Development of cyanopyridine–triazine hybrids as lead multitarget anti-Alzheimer agents

This publication has 41 references indexed in Scilit:

• Pivotal role of glycogen synthase kinase-3: A therapeutic target for Alzheimer's disease
  European Journal of Medicinal Chemistry, 2016
• Towards Disease-Modifying Treatment of Alzheimers Disease: Drugs Targeting β -Amyloid
  Current Alzheimer Research, 2010
• Amyloid-β-Acetylcholinesterase complexes potentiate neurodegenerative changes induced by the Aβ peptide. Implications for the pathogenesis of Alzheimer's disease
  Molecular Neurodegeneration, 2010
• Alzheimer disease: Time to improve its diagnosis and treatment
  Cleveland Clinic Journal of Medicine, 2009
• Substrate and Product Trafficking through the Active Center Gorge of Acetylcholinesterase Analyzed by Crystallography and Equilibrium Binding
  Journal of Biological Chemistry, 2006
• Cholinesterase inhibitors: new roles and therapeutic alternatives
  Pharmacological Research, 2004
• Kinetic and Structural Studies on the Interaction of Cholinesterases with the Anti-Alzheimer Drug Rivastigmine^,
  Biochemistry, 2002
• Mechanisms of Neuronal Degeneration in Alzheimer's Disease
  Neuron, 1996
• Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the Enzyme
  Neuron, 1996
• über eigenartige Krankheitsfälle des späteren Alters
  Zeitschrift für die gesamte Neurologie und Psychiatrie, 1911